Clinical characteristics and management of unipolar depressive disorders comorbid with neurological disorders

Neuropsychobiology

Volumn 37, Issue 2, 1998, Pages 84-87

  Judd, Lewis L ^a,b   Kunovac, Jelena L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Comorbidity; Neurological disorders; Unipolar depression

Indexed keywords

ANTIDEPRESSANT AGENT; PSYCHOTROPIC AGENT;

COMORBIDITY; CONFERENCE PAPER; DEMENTIA; DEPRESSION; HUMAN; HUNTINGTON CHOREA; LENGTH OF STAY; MAJOR DEPRESSION; NEUROLOGIC DISEASE; PARKINSON DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; SPINAL CORD INJURY; STROKE;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 0031913843     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026483     Document Type: Conference Paper

References (21)

1. Maldonado JL, Fernandez F, Garza-Trevino ES, Levy JK: Depression and its treatment in neurological disease. Psychiatr Ann 1997;27: 341-346.
2. Jones BN, Reifler BV: Depression coexisting with dementia. Evaluation and treatment. Med Clin North Am 1994;78:823-840.
3. Judd LL, Kunovac JL: The prevalence and consequences of depressive disorders comorbid with general medical illness. Int Acad Biomed Drug Res, in press.
4. Migliorelli R, Teson A, Sabe L, Petracchi M, Lciguarda R, Starkstein SE: Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease. Am J Psychiat 1995;152:37-44.
5. Cummings JL: Depression and Parkinson's disease: A review. Am J Psychiat 1992;149: 443-454.
6. Gustafson Y, Nilsson I, Mattsson M, Astrom M, Bucht G: Epidemiology and treatment of post-stroke depression. Drugs Aging 1995;7: 298-309.
7. Francisco GS: An overview of post-stroke depression. NJ Med 1993;90:686-689.
8. Andersen G, Vestergaard K, Riis J, Lauritzen L: Incidence of post-stroke depression during the first year in a large unselected stroke population determined using a valid standardized rating scale. Acta Psychiatr Scand 1994;90: 190-195.
9. Astrom M, Adolfsson R, Asplund K: Major depression in stroke patients. A 3-year longitudinal study. Stroke 1993;24:976-982.
10. Herrmann M, Bartels C, Schumacher M, Wallesch CW: Poststroke depression. Is there a pathoanatomic correlate for depression in the postacute stage of stroke? Stroke 1995;26:850-856.
11. Robinson RG, Lipsey JR, Rao K, Price TR: Two-year longitudinal study of post-stroke mood disorders: Comparison of acute-onset with delayed-onset depression. Am J Psychiat 1986;143(10):1238-1244.
12. Iacoboni M, Padovani A, Di Piero V, Lenzi GL: Post-stroke depression: Relationships with morphological damage and cognition over time. Ital J Neurol Sci 1995;16:209-216.
13. Morris PL, Raphael B, Robinson RG: Clinical depression is associated with impaired recovery from stroke. Med J Aust 1992;157:239-242.
14. Downhill JE Jr, Robinson RG: Longitudinal assessment of depression and cognitive impairment following stroke. J Nerv Ment Dis 1994; 182:425-431.
15. Cummings JI: Behavioral and psychiatric symptoms associated with huntington's disease. Adv Ncurol 1995;65:178-186.
16. Kishi Y, Robinson RG, Forrester AW: Comparison between acute and delayed onset major depression after spinal cord injury. J Nerv Ment Dis 1995;183:286-292.
17. Kishi Y, Robinson RG, Forrester AW: Prospective longitudinal study of depression following spinal cord injury. J Neuropsychiatry Clin Neurosci 1994;6:237-244.
18. Klaassen T, Verhey FRJ, Sneiders GHJM. Rozendaal N, de Vet HCW, van Pragg HM: Treatment of depression in Parkinson's disease: A meta-analysis. J Neuropsychiatry Clin Neurosci 1995;7:281-286.
19. Gottfries CG: Scandinavian experience with citalopram in the elderly. Int Clin Psychopharmacol 1996;(suppl 1):41-44.
20. Stamenkovic M, Schindler S, Kasper S: Therapy of poststroke depression with fluoxetine. A pilot project. Nervenarzt 1996;67:62-67.
21. Goetz CG, Tanner CM, Klawans HL: Bupropion in Parkinson's disease. Neurology 1984; 34:1092-1094.